MANORG
Mangalam Organics Limited
Specialty and pine chemicals including camphor, dipentene and synthetic resins
Commodities›Chemicals›Chemicals & Petrochemicals›Commodity Chemicals
mangalamorganics.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Mangalam Organics makes camphor, other terpene chemicals and synthetic resins, sells them to industrial customers, and also sells camphor-based consumer products under brands such as CamPure and Mangalam.
Company snapshot
22ndBy market cap
Ranked among 24 companies in Commodity Chemicals.
What we see
- ✗Over the last three years operations used more cash than they brought in, despite an operating profit — the business is not yet turning its profit into cash.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 169 Cr | 111 Cr | 105 Cr | 118 Cr | 138 Cr | 124 Cr | 150 Cr | 147 Cr | 158 Cr | 164 Cr | 154 Cr | 179 Cr |
| Operating expenses (approx.) | 159 Cr | 101 Cr | 95 Cr | 107 Cr | 126 Cr | 108 Cr | 130 Cr | 125 Cr | 158 Cr | 145 Cr | 107 Cr | 157 Cr |
| EBITDA | 10 Cr | 10 Cr | 10 Cr | 11 Cr | 12 Cr | 16 Cr | 20 Cr | 22 Cr | 0.27 Cr | 19 Cr | 47 Cr | 22 Cr |
| OPM % | 5.7% | 9.0% | 9.7% | 9.2% | 8.9% | 12.7% | 13.1% | 14.7% | 0.2% | 11.7% | 30.4% | 12.4% |
| Other income | 0.07 Cr | 0.04 Cr | 0.25 Cr | 0.21 Cr | 0.11 Cr | 0.0061 Cr | 0.0069 Cr | 4 Cr | 21 Cr | 0 Cr | -20 Cr | 0.08 Cr |
| Interest | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 6 Cr | 8 Cr | 6 Cr | 7 Cr | 8 Cr | 7 Cr | 7 Cr |
| Depreciation | 5 Cr | 5 Cr | 5 Cr | 5 Cr | 5 Cr | 5 Cr | 6 Cr | 5 Cr | 6 Cr | 6 Cr | 10 Cr | 6 Cr |
| Profit before tax | 0.74 Cr | 1 Cr | 3 Cr | 2 Cr | 3 Cr | 5 Cr | 7 Cr | 15 Cr | 4 Cr | 5 Cr | 9 Cr | 9 Cr |
| Tax % | 14.6% | 12.8% | 20.6% | 20.1% | 30.6% | 24.8% | 22.1% | 16.7% | 23.2% | 20.9% | 33.2% | 16.5% |
| Net profit | 0.63 Cr | 0.90 Cr | 2 Cr | 2 Cr | 2 Cr | 4 Cr | 5 Cr | 12 Cr | 3 Cr | 4 Cr | 6 Cr | 7 Cr |
| EPS (₹) | ₹0.83 | ₹1.05 | ₹2.87 | ₹1.95 | ₹2.48 | ₹4.25 | ₹5.92 | ₹14.28 | ₹3.73 | ₹5.07 | ₹6.56 | ₹8.49 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 338 Cr | 491 Cr | 493 Cr | 494 Cr | 530 Cr | 623 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 210 Cr | 400 Cr | 495 Cr | 455 Cr | 471 Cr | 535 Cr | Sign in free for the trailing twelve months |
| EBITDA | 128 Cr | 91 Cr | -3 Cr | 39 Cr | 59 Cr | 88 Cr | Sign in free for the trailing twelve months |
| OPM % | 37.8% | 18.5% | -0.6% | 7.8% | 11.1% | 14.1% | Sign in free for the trailing twelve months |
| Other income | 1 Cr | 1 Cr | 0.34 Cr | 0.78 Cr | 0.33 Cr | 5 Cr | Sign in free for the trailing twelve months |
| Interest | 1 Cr | 4 Cr | 14 Cr | 16 Cr | 21 Cr | 28 Cr | Sign in free for the trailing twelve months |
| Depreciation | 14 Cr | 15 Cr | 18 Cr | 20 Cr | 21 Cr | 28 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 114 Cr | 73 Cr | -34 Cr | 5 Cr | 17 Cr | 33 Cr | Sign in free for the trailing twelve months |
| Tax % | 25.7% | 26.6% | 19.4% | 20.5% | 24.2% | 22.7% | Sign in free for the trailing twelve months |
| Net profit | 85 Cr | 54 Cr | -27 Cr | 4 Cr | 13 Cr | 26 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹98.82 | ₹62.68 | ₹-31.63 | ₹4.92 | ₹14.60 | ₹29.64 | Sign in free for the trailing twelve months |
| Dividend payout % | 1.0% | 2.4% | — | 0.0% | 0.0% | 0.0% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 9 Cr | 9 Cr | 9 Cr | 9 Cr | 9 Cr | 9 Cr |
| Reserves | 243 Cr | 296 Cr | 267 Cr | 272 Cr | 285 Cr | 310 Cr |
| Borrowings | 24 Cr | 212 Cr | 190 Cr | 173 Cr | 268 Cr | 356 Cr |
| Other liabilities | 36 Cr | 44 Cr | 40 Cr | 32 Cr | 62 Cr | 65 Cr |
| Total liabilities | 311 Cr | 560 Cr | 506 Cr | 485 Cr | 624 Cr | 740 Cr |
| Fixed assets (net) | 121 Cr | 198 Cr | 227 Cr | 244 Cr | 265 Cr | 323 Cr |
| CWIP | 0 Cr | 8 Cr | 1 Cr | 5 Cr | 26 Cr | 0 Cr |
| Investments | 0.0025 Cr | 0.0025 Cr | 0.30 Cr | 0.30 Cr | 0.30 Cr | 0.30 Cr |
| Loans & advances | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 18 Cr | 0 Cr |
| Inventories | 106 Cr | 244 Cr | 189 Cr | 136 Cr | 213 Cr | 300 Cr |
| Trade receivables | 34 Cr | 44 Cr | 47 Cr | 56 Cr | 69 Cr | 59 Cr |
| Cash & bank | 1 Cr | 0.51 Cr | 1 Cr | 2 Cr | 0.47 Cr | 1 Cr |
| Other assets | 49 Cr | 66 Cr | 39 Cr | 43 Cr | 31 Cr | 56 Cr |
| Total assets | 311 Cr | 560 Cr | 506 Cr | 485 Cr | 624 Cr | 740 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operating activity | 26 Cr | -83 Cr | 64 Cr | 58 Cr | -51 Cr | -55 Cr |
| Cash from investing | -28 Cr | -100 Cr | -41 Cr | -40 Cr | -67 Cr | -60 Cr |
| Cash from financing | 2 Cr | 182 Cr | -23 Cr | -17 Cr | 117 Cr | 116 Cr |
| Net cash flow | 0.40 Cr | -0.53 Cr | 0.57 Cr | 0.66 Cr | -1 Cr | 0.65 Cr |
| Free cash flow (OCF − Capex) | 26 Cr | -183 Cr | 23 Cr | 18 Cr | -118 Cr | -119 Cr |
Ratios
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ROCE % | 41.8% | 15.0% | -4.3% | 4.6% | 6.8% | 9.1% |
| ROE % | 33.7% | 17.7% | -9.9% | 1.5% | 4.3% | 8.1% |
| Debtor days | 37 | 33 | 35 | 41 | 48 | 34 |
| Inventory days | 263 | 312 | 168 | 191 | 248 | 299 |
| Days payable | 60 | 42 | 29 | 33 | 60 | 46 |
| Cash conversion cycle | 240 | 303 | 174 | 199 | 236 | 288 |
| OCF / EBITDA % | 20.6% | -91.3% | — | 148.9% | -86.7% | -63.1% |
| OCF / EBITDA % (3 years) | — | — | 3.3% | 30.3% | 74.8% | -26.3% |
| Debt / equity | 0.10 | 0.70 | 0.69 | 0.62 | 0.91 | 1.12 |
| Current ratio | 3.55 | 1.76 | 1.42 | 1.24 | 1.09 | 1.14 |
| Net debt / EBITDA | 0.18 | 2.32 | — | 4.43 | 4.57 | 4.04 |